A new way of using DNA to kill cancer cells could pave the way for a cure, scientists say

A new way of using DNA to kill cancer cells could pave the way for a cure, scientists say

A new way of using DNA to kill cancer cells could pave the way for a cure, scientists say

A new way of using DNA to kill cancer cells could pave the way for a cure, scientists say

  • Scientists at the University of Tokyo may have paved the way for using DNA to treat cancer
  • Study author Professor Akimitsu Okamoto says their research is ‘good news’
  • It uses DNA in the form of a cancer-killing clip, which is injected into cancer cells

Scientists have devised a new way of using DNA to kill cancer cells that could pave the way for a cure for the disease.

Professor Akimitsu Okamoto from the University of Tokyo and author of the study, said the research was ‘good news’ and would open up new possibilities for cancer treatment.

The method is aimed at cervical cancer cells in humans and breast cancer, as well as malignant melanoma cells in mice.

It uses a pair of cancer-killing hairpin DNA that is injected into cancer cells.

A new way of using DNA to kill cancer cells could pave the way for a cure, scientists say

Professor Akimitsu Okamoto (pictured) of the University of Tokyo has a new way of using DNA to kill cancer cells which could pave the way for a cure, he said the research was “good news” and would open up new possibilities for cancer treatment

The method devised by scientists from the University of Tokyo (pictured) targets human cervical and breast cancer cells, as well as malignant melanoma cells in mice

The method devised by scientists from the University of Tokyo (pictured) targets human cervical and breast cancer cells, as well as malignant melanoma cells in mice

When they were injected, they bound to molecules called microRNAs, which are overproduced in certain types of cancer.

After binding to microRNAs, they unraveled and formed longer strands of DNA that generated an immune response.

The immune system recognized the overproduced microRNA cells as dangerous, which activated a natural immune response that killed the cancer cells.

The Japanese research team says their method is different from existing ones and could herald a new era of breakthrough cancer drugs.

Professor Okamoto said: ‘The results of this study are good news for doctors, drug discovery researchers and cancer patients, as we believe they will give them new opportunities for drug development and drug policy.

‘We will further pursue drug discovery based on the results of this research and examine in detail the efficacy, toxicity and potential methods of drug administration.’

He added: ‘We thought that if we could create new drugs that work through a different mechanism of action than conventional drugs, they might be effective against cancers that have been incurable so far.’

New cancer research uses a pair of cancer-killing hairpin-shaped DNA that is injected into cancer cells

New cancer research uses a pair of cancer-killing hairpin-shaped DNA that is injected into cancer cells

Cancer is an unfortunately known health concern and existing ways of treating it have their limitations, but it is expected that drugs based on DNA and RNA will help scientists to eventually defeat it.

This is because DNA and RNA are vital molecules that carry information and can control the biological function of cells.

They are expected to transform the future of medicine and help treat other hard-to-treat diseases caused by viruses and genetic diseases.

Using DNA and RNA to treat cancer has been difficult because it is difficult to get them to distinguish between cancerous and healthy cells.

This means that the patient’s immune system can be damaged if healthy cells are attacked.

However, this was the first time scientists were able to develop a hairpin-shaped strand of DNA that can activate the natural immune response to target and kill specific cancer cells.

The findings were published in the Journal of the American Chemical Society.

title_words_as_hashtags]

Leave a Comment

Your email address will not be published. Required fields are marked *